Louis Fabri
- Molecular Biology top 5%
- Oncology top 2%
- Immunology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Andrew D. NashDouglas J. HiltonNicos A. NicolaEdouard C. NiceTracy A. WillsonManuel BacaDonald MetcalfDavid P. De Souza
- Topics
- Monoclonal and Polyclonal Antibodies Research (19 papers)Cytokine Signaling Pathways and Interactions (10 papers)Glycosylation and Glycoproteins Research (9 papers)
- Cited by
- OncologyImmunologyPharmacology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- AustraliaUnited StatesSweden
In The Last Decade
Louis Fabri
55 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 1.4k
- Oncology 1.1k
- Immunology 771
- Radiology, Nuclear Medicine and Imaging 319
- Endocrinology, Diabetes and Metabolism 227
Countries citing papers authored by Louis Fabri
This map shows the geographic impact of Louis Fabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Fabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Fabri more than expected).
Fields of papers citing papers by Louis Fabri
This network shows the impact of papers produced by Louis Fabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Fabri. The network helps show where Louis Fabri may publish in the future.
Co-authorship network of co-authors of Louis Fabri
This figure shows the co-authorship network connecting the top 25 collaborators of Louis Fabri. A scholar is included among the top collaborators of Louis Fabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Fabri. Louis Fabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 56 | |
| 7 | 22 | |
| 8 | 106 | |
| 9 | 8 | |
| 10 | 23 | |
| 11 | 13 | |
| 12 | 143 | |
| 13 | 4 | |
| 14 | 23 | |
| 15 | 67 | |
| 16 | 7 | |
| 17 | Characterization of bovine heparin-binding neurotrophic factor (HBNF): assignment of disulfide bonds. | 11 |
| 18 | 19 | |
| 19 | 47 | |
| 20 | 14 |
About Louis Fabri
Louis Fabri is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 55 papers that have together received 2.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Glycosylation and Glycoproteins Research (9 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (771 citations) and Pharmacology (185 citations). Louis Fabri has collaborated with scholars based in Australia, United States and Sweden. Frequent co-authors include Andrew D. Nash, Douglas J. Hilton, Nicos A. Nicola, Edouard C. Nice, Tracy A. Willson, Manuel Baca, Donald Metcalf, David P. De Souza, Jian‐Guo Zhang and Antony W. Burgess. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.